Embolisation de l'artère utérine en Israël — obtenez 3 cliniques correspondantes avec les coûts

Uterine Artery Embolization (UAE) is a minimally invasive treatment for fibroids and adenomyosis. An interventional radiologist inserts embolic particles to block blood flow to abnormal tissue. This process starves growths of nutrients, causing them to shrink while preserving the uterus.

• Procedure method: Interventional radiologists guide a catheter through arteries using real-time X-ray imaging.
• Treatment goal: Microscopic beads block uterine arteries to shrink fibroids by 30% to 75%.
• Hospitalization needs: Some patients require hospital stays for intensive post-procedure pain management.
• Recovery period: Physical recovery takes 7 days, with full clinical results appearing within 6 months.

Bookimed Expert Insight: Israeli centers like Sourasky Medical Center provide multidisciplinary care under JCI accreditation. Data shows these top-tier institutions often combine interventional radiology with gynecological expertise. This collaboration is vital because post-procedure pain can be intense, requiring specialist-led management plans. Some centers even bundle free airport transfers and interpreters into their care model.

Patient Consensus: Many patients emphasize that while recovery is fast, you should prepare for extreme initial pain. Most survivors recommend securing a solid pain management plan before starting the procedure.

Uterine Artery Embolization allows for successful pregnancy, particularly in patients under 40. However, it carries a higher risk of complications like miscarriage or placental abnormalities compared to myomectomy. Fertility specialists often reserve this minimally invasive procedure for patients who cannot undergo traditional surgery.

• Success rates: Post-procedure pregnancy rates range from 40% to 69% in most patients.
• Ovarian function: Fewer than 5% of women experience premature menopause or loss of menstruation.
• Clinical preferences: Surgeons typically prioritize myomectomy for patients whose primary goal is future fertility.
• Pregnancy risks: Patients face higher chances of premature delivery and low birth weight babies.

Bookimed Expert Insight: Israeli specialists like Prof. Dan Grisaro at Sourasky Medical Center prioritize fertility-sparing techniques. Patients often choose Israel for advanced robotic myomectomy rather than embolization. This approach helps preserve uterine tissue by utilizing the Da Vinci robotic system. Data shows clinics here provide specialized care for high-risk pregnancies occurring after fibroid treatments.

Patient Consensus: Patients emphasize the need for an obstetrician experienced in post-embolization care. Many survivors highlight that while pregnancy is possible, monitoring for early ovarian decline is vital.

Uterine artery embolization in Israel is a safe, minimally invasive alternative to surgery. While the procedure carries lower risk than hysterectomy, patients typically experience post-embolization syndrome. Serious complications like infection or premature menopause are rare but require medical screening by JCI-accredited specialists.

• Post-embolization syndrome: Expect temporary fever, chills, and nausea for 24–72 hours after the procedure.
• Pain management: Intense uterine cramping usually requires hospital stay and IV pain medication.
• Ovarian impact: Women over 45 face a slight risk of early menopause from particle migration.
• Recovery timeline: Most patients see cycle normalization and symptom relief within 3–6 months.

Bookimed Expert Insight: Sourasky Medical Center performs 34,000 operations annually under JCI standards. Data shows that clinics here prioritize pain management protocols. Patients often receive specialized IV pain pumps. This proactive approach manages the intense post-procedural cramping better than outpatient clinics elsewhere.

Patient Consensus: Many patients describe the procedure itself as painless thanks to sedation. However, they emphasize being prepared for heavy cramping that feels like intense labor shortly after.

New fibroids can develop after treatment because procedures like Uterine Artery Embolization only target existing growths. While treated fibroids usually shrink and die, the remaining uterine tissue remains susceptible to new formations driven by hormonal factors and genetic predisposition.

• Recurrence rate: Up to 50% of patients may develop new fibroids within 10 years.
• Growth timeframe: New fibroids can appear rapidly, sometimes within 2 years after your procedure.
• Monitoring protocol: Physicians recommend MRI or ultrasound every 6–12 months to detect early new growths.
• Permanent solution: Only a hysterectomy offers a 100% guarantee against future fibroid formation.

Bookimed Expert Insight: Israeli specialists like Prof. Dan Grisaro at Sourasky Medical Center leverage advanced imaging to distinguish between treated tissue and new growths. Choosing a JCI-accredited facility in Tel Aviv ensures access to high-resolution monitoring that caught new developments earlier in 1.8 million annual patient cases.

Patient Consensus: Patients emphasize distinguishing between treated fibroid shrinkage and entirely new growths. Many suggest hormonal management after the procedure to help slow down potential future formations.

Uterine Artery Embolization effectively treats large and giant fibroids by reducing volume by 40-50% within 6 months. Most patients experience significant symptom relief from heavy bleeding and pressure, including those with multiple or bulky growths, in Joint Commission International-accredited Israeli medical centers.

• Success rates: Nearly 90% of patients achieve long-term relief from pelvic pain and bleeding.
• Giant fibroids: The procedure successfully treats growths exceeding 10 cm without decreasing efficacy.
• Recovery focus: Most patients return to full activity within 7 to 10 days post-procedure.
• Advanced diagnostics: Radiologists use high-resolution MRI scans to map vascular structures before embolization.

Bookimed Expert Insight: While Israeli centers like Sourasky Medical Center offer advanced embolization, their top-tier gynecologists like Dr. Dan Grisaro often perform robotic myomectomy too. This dual expertise ensures you receive the method best suited for your specific fibroid location, especially for subserosal types.

Patient Consensus: Many patients notice bleeding and pain improve within 1 month, though they emphasize having a strong pain management plan for the first 3 days. While fibroids shrink significantly, they typically remain as calcified tissue rather than disappearing entirely.

Recovery after Uterine Artery Embolization in Israel typically takes 7 to 14 days for a return to normal daily activities. Most patients achieve full physical normalcy and stop pain medications by the end of the second week following this minimally invasive endovascular procedure.

• Initial recovery: Patients often feel ready for desk work by day 6 post-procedure.
• Pain management: Most intense discomfort peaks 6 hours after embolization and lasts 48 hours.
• Health monitoring: Post-embolization syndrome symptoms like fatigue or fever may persist for two weeks.
• Activity restrictions: Heavy lifting and sexual activity are typically restricted for at least two weeks.

Bookimed Expert Insight: While patients often feel improved by day 3, overexertion during this window frequently triggers fatigue-related setbacks. Sourasky Medical Center data shows that sticking to a full 14-day recovery plan ensures better long-term outcomes for fibroid treatment.

Patient Consensus: Expect the first 2 days to be challenging due to pain, but energy levels usually return quickly. Planning for a full two weeks off prevents the discomfort often caused by sitting for long periods too soon.

Uterine artery embolization in Israel is typically performed under conscious sedation combined with local anesthesia rather than general anesthesia. Specialists like Dr. Dan Grisaro at Sourasky Medical Center utilize this twilight sedation to ensure patient comfort while allowing for real-time monitoring and faster recovery.

• Anesthesia type: Moderate sedation keeps you relaxed and sleepy throughout the procedure.
• Local numbing: Local anesthetic blocks pain at the femoral or radial entry point.
• Access sites: Doctors insert thin catheters through either the groin or the wrist.
• Surgical alternative: Unlike hysterectomies, this minimally invasive method avoids airway management risks.

Bookimed Expert Insight: While most clinics follow standard sedation protocols, centers like Sourasky Medical Center (Ichilov) leverage their high volume of 34,000 yearly operations to refine pain management. They often prioritize radial artery access which may reduce post-procedure downtime compared to traditional groin access.

Patient Consensus: While the procedure itself feels painless, patients should prepare for intense cramping starting 30 minutes after completion. This heavy pressure is a normal sign that the fibroids are losing their blood supply.